SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
-6.05%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$341M
AUM Growth
+$341M
(+30%)
Cap. Flow
+$89.5M
Cap. Flow
% of AUM
26.25%
Top 10 Holdings %
Top 10 Hldgs %
69.46%
Holding
33
New
7
Increased
16
Reduced
6
Closed
4
Top Buys
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$25.2M |
| 2 |
Viatris
VTRS
|
$23.4M |
| 3 |
GSK
GSK
|
$23.3M |
| 4 |
Enanta Pharmaceuticals
ENTA
|
$12.3M |
| 5 |
CONMED
CNMD
|
$9.59M |
Top Sells
| 1 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$14.6M |
| 2 |
Amgen
AMGN
|
$14.1M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$12.9M |
| 4 |
Cardinal Health
CAH
|
$6.56M |
| 5 |
Community Health Systems
CYH
|
$5.85M |
Sector Composition
| 1 | Healthcare | 91.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Viatris
VTRS
$12.3B
| $32.1M | 9.41% |
705,500
+514,800
| +270% | +$23.4M |
|
|
2
GSK
GSK
$79.9B
| $30.7M | 9.01% |
668,200
+507,100
| +315% | +$23.3M |
|
3
Teva Pharmaceuticals
TEVA
$21.1B
| $30.6M | 8.96% |
568,396
+77,400
| +16% | +$4.16M |
|
4
Sanofi
SNY
$121B
| $27.5M | 8.08% |
488,100
+9,500
| +2% | +$536K |
|
|
COV
5
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $25.2M | 7.39% |
+291,500
| New | +$25.2M |
|
6
AbbVie
ABBV
$372B
| $24.9M | 7.31% |
431,400
+121,805
| +39% | +$7.04M |
|
|
7
Enanta Pharmaceuticals
ENTA
$180M
| $22.4M | 6.58% |
566,903
+311,775
| +122% | +$12.3M |
|
|
8
Community Health Systems
CYH
$387M
| $17.2M | 5.06% |
314,700
-106,700
| -25% | -$5.85M |
|
9
Medtronic
MDT
$119B
| $14.8M | 4.33% |
238,100
+91,000
| +62% | +$5.64M |
|
|
MGLN
10
DELISTED
Magellan Health Services, Inc.
MGLN
| $11.4M | 3.34% |
208,300
+100,100
| +93% | +$5.48M |
|
|
AGN
11
DELISTED
ALLERGAN INC
AGN
| $10.2M | 2.99% |
57,300
+5,400
| +10% | +$962K |
|
|
12
CONMED
CNMD
$1.68B
| $9.59M | 2.81% |
+260,400
| New | +$9.59M |
|
13
Orthofix Medical
OFIX
$592M
| $9.34M | 2.74% |
301,598
-89,300
| -23% | -$2.76M |
|
14
Biogen
BIIB
$19.4B
| $8.87M | 2.6% |
+26,800
| New | +$8.87M |
|
15
Insmed
INSM
$28.8B
| $8.66M | 2.54% |
663,300
-155,400
| -19% | -$2.03M |
|
|
RPRX
16
DELISTED
Repros Therapeutics Inc.
RPRX
| $7.46M | 2.19% |
+753,600
| New | +$7.46M |
|
|
XNPT
17
DELISTED
XENOPORT, INC.
XNPT
| $7.18M | 2.11% |
1,335,300
+162,600
| +14% | +$875K |
|
|
RAD
18
DELISTED
Rite Aid Corporation
RAD
| $5.97M | 1.75% |
+1,234,000
| New | +$5.97M |
|
|
MNTA
19
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $5.16M | 1.51% |
454,600
+69,700
| +18% | +$790K |
|
|
SGNT
20
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $4.82M | 1.41% |
154,900
-28,200
| -15% | -$877K |
|
|
WCG
21
DELISTED
Wellcare Health Plans, Inc.
WCG
| $4.57M | 1.34% |
75,700
-3,400
| -4% | -$205K |
|
22
Rigel Pharmaceuticals
RIGL
$697M
| $4.03M | 1.18% |
2,074,400
+1,151,200
| +125% | +$2.23M |
|
|
FPRX
23
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $3.5M | 1.03% |
298,300
+36,300
| +14% | +$426K |
|
|
CORI
24
DELISTED
Corium International, Inc.
CORI
| $3.43M | 1.01% |
558,820
+47,320
| +9% | +$291K |
|
|
CNCE
25
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $3.29M | 0.97% |
+261,200
| New | +$3.29M |
|